AIM ImmunoTech Inc. Research And Development Expense

• AIM ImmunoTech Inc. showed a decrease of -36.7% in Research And Development Expense from 2024 to 2025.
• This data is from AIM ImmunoTech Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), AIM ImmunoTech Inc.'s Research And Development Expense has declined by 43.9%.
• Historical annual values: Fiscal year 2025: $3.92 million | Fiscal year 2024: $6.20 million | Fiscal year 2023: $10.94 million | Fiscal year 2022: $6.99 million | Fiscal year 2021: $7.67 million | Fiscal year 2020: $5.72 million | Fiscal year 2019: $4.65 million | Fiscal year 2018: $4.78 million | Fiscal year 2017: $4.10 million | Fiscal year 2016: $5.11 million | Fiscal year 2015: $8.04 million | Fiscal year 2014: $8.99 million | Fiscal year 2013: $8.36 million | Fiscal year 2012: $9.51 million | Fiscal year 2011: $6.72 million | Fiscal year 2010: $7.61 million | Fiscal year 2009: $7.00 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026